Allegion (NYSE:ALLE) Issues FY 2026 Earnings Guidance

Allegion (NYSE:ALLE) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 8.700-8.900 for the period, compared to the consensus EPS estimate of 8.830. The company issued revenue guidance of $4.3 billion-$4.4 billion, compared to the consensus revenue estimate of $4.3 billion.

Wall Street Analysts Forecast Growth

ALLE has been the subject of a number of recent research reports. Wells Fargo & Company reiterated a “positive” rating on shares of Allegion in a research note on Tuesday, December 16th. JPMorgan Chase & Co. dropped their price target on shares of Allegion from $190.00 to $180.00 and set an “overweight” rating for the company in a research report on Wednesday. Weiss Ratings restated a “buy (b)” rating on shares of Allegion in a research report on Wednesday, January 21st. Finally, Barclays dropped their target price on shares of Allegion from $187.00 to $180.00 and set an “equal weight” rating for the company in a report on Wednesday, January 7th. Three equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, Allegion has an average rating of “Hold” and an average price target of $175.50.

Allegion Stock Performance

ALLE opened at $162.70 on Thursday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.11 and a current ratio of 1.84. The stock has a market capitalization of $14.00 billion, a price-to-earnings ratio of 21.87, a PEG ratio of 2.98 and a beta of 1.03. The company has a fifty day moving average of $165.49 and a 200 day moving average of $168.17. Allegion has a fifty-two week low of $116.57 and a fifty-two week high of $183.11.

Allegion (NYSE:ALLE) last released its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $1.94 EPS for the quarter, missing the consensus estimate of $2.01 by ($0.07). The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.04 billion. Allegion had a net margin of 15.83% and a return on equity of 38.06%. The firm’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period last year, the company earned $1.86 EPS. Allegion has set its FY 2026 guidance at 8.700-8.900 EPS. As a group, sell-side analysts forecast that Allegion will post 7.77 earnings per share for the current fiscal year.

Allegion Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, March 13th. This is a positive change from Allegion’s previous quarterly dividend of $0.51. Allegion’s dividend payout ratio is presently 27.60%.

Institutional Investors Weigh In On Allegion

Hedge funds have recently bought and sold shares of the business. Boston Partners grew its holdings in Allegion by 1.0% during the 3rd quarter. Boston Partners now owns 4,746,454 shares of the scientific and technical instruments company’s stock valued at $842,026,000 after purchasing an additional 48,199 shares during the last quarter. State Street Corp boosted its position in shares of Allegion by 6.6% during the third quarter. State Street Corp now owns 4,232,208 shares of the scientific and technical instruments company’s stock valued at $750,584,000 after buying an additional 260,973 shares during the period. Northern Trust Corp grew its stake in shares of Allegion by 4.5% during the third quarter. Northern Trust Corp now owns 1,210,063 shares of the scientific and technical instruments company’s stock valued at $214,605,000 after buying an additional 52,612 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Allegion by 26.7% in the third quarter. Bank of America Corp DE now owns 863,837 shares of the scientific and technical instruments company’s stock worth $153,202,000 after buying an additional 181,869 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Allegion by 1.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 757,545 shares of the scientific and technical instruments company’s stock worth $120,616,000 after acquiring an additional 11,191 shares during the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

Allegion Company Profile

Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is head­quartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.

The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.